NCT04373291View on ClinicalTrials.gov

Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic

PHASE3CompletedINTERVENTIONAL
Enrollment

1,293

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

October 1, 2021

Conditions
COVID-19Non-specific Effects of VaccinesMorbidityAbsenteeismHeterologous Immunity
Interventions
BIOLOGICAL

BCG-Denmark

Participants randomized to receive BCG will receive one 0.1 ml dose of Mycobacterium bovis BCG live attenuated BCG-Denmark vaccine (AJ Vaccines, Copenhagen, Denmark) by intradermal injection in the left deltoid region.

BIOLOGICAL

Saline

Participants randomized to the control group will receive one 0.1 ml dose sterile 0.9 % NaCl by intradermal injection in the left deltoid region.

Trial Locations (1)

5000

University of Southern Denmark, Odense

All Listed Sponsors
collaborator

University of Southern Denmark

OTHER

lead

Bandim Health Project

OTHER

NCT04373291 - Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic | Biotech Hunter | Biotech Hunter